Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

108.65
BATS BZX Real-Time Price
As of 2:14pm ET
 +0.45 / +0.42%
Today’s Change
94.55
Today|||52-Week Range
147.17
-6.13%
Year-to-Date
7 Winners and Losers From Biggest Biotech Conference of 2017
Dec 13 / TheStreet.com - Paid Partner Content
Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta
Dec 11 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs
Dec 13 / Zacks.com - Paid Partner Content
Novartis Reports Updated Results from Kymriah's JULIET Study
Dec 11 / Zacks.com - Paid Partner Content
Juno Reports Additional Data on CAR-T Therapy, Shares Drop
Dec 12 / Zacks.com - Paid Partner Content
4 Stocks Move to Start the Week
Dec 11 / GuruFocus News - Paid Partner Content
Bluebird's Shares Jump on Strong Data for CAR-T Therapy
Dec 12 / Zacks.com - Paid Partner Content
Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today
Dec 11 / Zacks.com - Paid Partner Content
Bluebird Bio Stock Soars After Company Details Promising Cancer Treatment
Dec 11 / TheStreet.com - Paid Partner Content
Bluebird Bio Becoming Household Name With This Promising Cancer Treatment
Dec 11 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close108.20
Today’s open108.11
Day’s range107.94 - 109.50
Volume277,697
Average volume (3 months)6,219,831
Market cap$85.8B
Data as of 2:14pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.51%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+22.70%
P/E ratio25.5
Price/Sales8.51
Price/Book12.86

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-1.63-2.57%
GSKGlaxoSmithKline-0.38-1.07%
ABBVAbbVie-1.41-1.45%
SNYSanofi-0.72-1.64%
Data as of 2:14pm ET, 12/14/2017

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$1.92
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts